Afinitor® and Temodar®: An Active Regimen for Pancreatic Neuroendocrine Tumors (3/1/2010)
Researchers from Massachusetts General Hospital have reported that the combination of Afinitor® (everolimus) and Temodar® (temozolomide) is active for the treatment of patients with advanced pancreatic neuroendocrine tumors (NET). The details of this Phase I/II study were presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium (GCS).

PAM4 Enzyme May Help Detect Early-stage Pancreatic Cancer (2/25/2010)
Researchers from Garden State Cancer Center, the Johns Hopkins Medical Institutions, and New York University Medical Center have reported that an enzyme, PAM4, may be detected by serum enzyme immunoassay (EIA) in patients with early-stage pancreatic cancer. The details of this study were presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in late January.

Tarceva® Evaluated for Treatment of Pancreatic Cancer (2/24/2010)
Several studies evaluating Tarceva® (erlotinib) for the treatment of pancreatic cancer were presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium (GCS) in January.

Adjuvant Chemoradiotherapy May Improve Survival of Patients with Pancreatic Cancer (2/12/2010)
Researchers from the University of Miami have reported that adjuvant chemoradiotherapy, treatment in a high-volume hospital, and/or treatment in a teaching hospital were independent predictors of survival in patients treated with surgical resection for pancreatic cancer. The details of this study were published in the January, 2010 issue of the Archives of Surgery.

Sugary Soft Drink Consumption May Increase Risk of Developing Pancreatic Cancer (2/11/2010)
Researchers affiliated with the Singapore Chinese Health Study have reported that individuals who consumed two or more sugary soft drinks per week experienced a statistically significant increased risk of pancreatic cancer when compared with individuals who did not consume soft drinks. The details of this study appeared in the February, 2010 issue of Cancer Epidemiology, Biomarkers, and Prevention.